Sectors
Foley & Lardner LLP partner Aaron Maguregui commented in the Medical Device Network article, “AI proliferation in healthcare shines light on HIPAA shortcomings,” assessing the rise and accompanying risks of artificial intelligence in health care.
“HIPAA was intended to scale with time and with technology,” Maguregui said. “What I don’t think HIPAA ever contemplated was the fact that AI would be able to essentially take in data from multiple sources, match it together, and create the potential for the reidentification of data that was never intended to be used for reidentification.”
While he does not view HIPAA as incompatible with the rapid advance of technology in health care, Maguregui noted that it needs updating to address evolving innovations.
“My wish for HIPAA would be to expand and update it, to understand where technology has gone, where compute has gone, and to improve the ability for innovation, the ability for vendors to have better access to data that will help them create better products, and to ultimately improve the patient and provider experience, and health care overall,” he added.
